Literature DB >> 3031724

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.

K Takayasu, Y Shima, Y Muramatsu, N Moriyama, T Yamada, M Makuuchi, H Hasegawa, S Hirohashi.   

Abstract

Thirty-one patients with hepatocellular carcinoma (HCC) were given either an intraarterial injection of iodized poppyseed oil (Lipiodol) alone (group A, n = 6), an emulsion of iodized oil and doxorubicin hydrochloride (Adriamycin) (group B, n = 15), or chemoembolization with the same emulsion followed by gelatin sponge (Gelfoam) particles (group C, n = 10). Hepatic resection was subsequently performed. The frequencies of complete necrosis of tumor in the main lesion, daughter tumors, tumor thrombus, and foci of intracapsular invasion were evaluated in the cut surface of the resected specimen. Group C demonstrated the best therapeutic effects, showing complete necrosis of the main lesion in 83% (P less than .01), daughter tumors in 53% (P less than .01), tumor thrombus in 17%, and foci of intracapsular invasion in 67%. These results are superior to those reported previously for chemoembolization without iodized oil. Group B showed better results than group A, but the difference was not significant. Iodized oil alone (group A) had practically no therapeutic effect but was helpful in differentiating small HCC from regenerative nodules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031724     DOI: 10.1148/radiology.163.2.3031724

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  74 in total

1.  Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.

Authors:  Markus Peck-Radosavljevic; Wolfgang Sieghart; Claus Kölblinger; Markus Reiter; Martin Schindl; Gregor Ulbrich; Rudolf Steininger; Christian Müller; Rudolf Stauber; Maximilian Schöniger-Hekele; Manfred Gschwendtner; Christina Plank; Martin Funovics; Ivo Graziadei; Johannes Lammer; Thomas Gruenberger; Günther Gastl; Franz Karnel
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

2.  Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Authors:  K Yamamoto; M Masuzawa; M Kato; T Okuyama; K Tamura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization.

Authors:  H Nakamura; H Oi; S Hori; Y Takayasu; S Furui; S Sawada; T Kozuka
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma.

Authors:  Yukinori Imai; Taku Chikayama; Manabu Nakazawa; Kazuhiro Watanabe; Satsuki Ando; Yoshie Mizuno; Kiyoko Yoshino; Kayoko Sugawara; Kazuhiro Hamaoka; Kenji Fujimori; Mie Inao; Nobuaki Nakayama; Masashi Oka; Sumiko Nagoshi; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2011-10-06       Impact factor: 7.527

Review 5.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

6.  Ablation of recurrent primary liver cancer using 131I-lipiodol.

Authors:  R Novell; A Hilson; K Hobbs
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

7.  Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.

Authors:  Toshihide Shima; Masayuki Mizuno; Hideaki Otsuji; Chiemi Mizuno; Hirozumi Obata; Hyohun Park; Shinobu Nakajo; Takeshi Okanoue
Journal:  J Med Ultrason (2001)       Date:  2005-09       Impact factor: 1.314

8.  Comparative study of different interventional therapies for primary liver cancer.

Authors:  Q Liu; Y C Jia; J M Tian; Z T Wang; H Ye; J J Yang; F Sun
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

9.  An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization.

Authors:  H Furukawa; T Hara; K Hoshino; T Taniguchi
Journal:  Gastroenterol Jpn       Date:  1991-12

10.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.